Prescription Drug Price Relief Act of 2025
Prescription Drug Price Relief Act of 2025
Plain Language Summary
# Prescription Drug Price Relief Act of 2025 - Summary **What the Bill Would Do** The Prescription Drug Price Relief Act of 2025 is designed to lower the cost of prescription medications for Americans. While specific details aren't available in the basic bill information provided, bills with this title typically aim to give the federal government more power to negotiate drug prices directly with pharmaceutical companies, similar to how Medicare can negotiate prices for some drugs.
The legislation would primarily affect patients who purchase prescription drugs, pharmaceutical companies that manufacture them, and Medicare/insurance programs. **Current Status** The bill (S 1818) was introduced in the 119th Congress by Senator Bernie Sanders (I-VT) and is currently in committee, meaning it hasn't yet been voted on by the full Senate. At this stage, it's being reviewed and discussed by the relevant Senate committee before any further action. **Next Steps for More Information** To understand the specific provisions and details of what this bill proposes, you would need to review the full text on Congress.gov or track its progress through the legislative process.
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.